At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 174 enrolled
Drug / intervention
Hydromorphonedrug
Likely dose
Hydromorphone 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influence of Body Size and Composition on Response to Hydromorphone in ED Patients With Acute Pain
In Brief
A Phase 2 clinical trial evaluating Hydromorphone for Pain. Completed, enrolled 174 participants across 2 sites.
Detailed Summary
Pain is the most common complaint for patients presenting to the emergency department (ED). Inadequate pain relief is also a common problem in ED. Patients' pain perceptions and responses to intravenous opioids vary widely and are influenced by multiple factors. The objective of the current study is to examine the association between total body weight, BMI (body mass index) and clinical response to a fixed dose of intravenous hydromorphone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedAug 2012
Primary CompletionOct 2012
Study CompletionDec 2012
TodayJul 2026
First PostedAug 30, 2012
Enrollment StartOct 1, 2011
Primary CompletionOct 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.8 years ago
Interventions
Hydromorphonedrug
a fixed dose (1 mg) of hydromorphone will be given to the study subjects